A 57-Week, Multicenter, Active-treatment, Open-label Extension Trial of CVL-865 as Adjunctive Therapy in Adults with Drug-Resistant Focal Onset Seizures.
- O'Brien, Terence (Primary Chief Investigator (PCI))
- Nicolo, John-Paul (Chief Investigator (CI))
- Nikpour, Armin (Chief Investigator (CI))
- Wijayath, Manori (Chief Investigator (CI))
- D'Souza, Wendyl Jude (Chief Investigator (CI))
- Reutens, David C. (Chief Investigator (CI))
- Carney, Patrick (Chief Investigator (CI))
- Somerville, Ernest Robertson (Chief Investigator (CI))
- Mullen, Saul Alator (Chief Investigator (CI))
- Frasca, Joseph (Chief Investigator (CI))
- Royal Brisbane and Women's Hospital
- University of Melbourne
- Royal Melbourne Hospital
- Alfred Hospital
- Royal Prince Alfred Hospital
- University of Sydney
- Westmead Hospital
- St Vincent's Hospital Melbourne
- University of Tasmania
- Capital Medical University
- Monash University
- Alfred Health
- University of Queensland
- Box Hill Hospital
- Prince of Wales Hospital (New South Wales)
- University of New South Wales (UNSW)
- Florey Institute of Neuroscience and Mental Health (FINMH) (Victoria)
- Olivia Newton-John Cancer Research Institute
- Austin Health
- Flinders Medical Centre (South Australia)
Project: Research